Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Quarterly Report

Iowa and Montana filed an 'original action' with the Supreme Court to block a merger between Paramount Skydance and Warner Brothers, valued at $110 billion, and to halt an antitrust enforcement action by 12 Democratic-led states. The Supreme Court has the authority to hear disputes between states directly, and the process involves filing a bill of complaint and potentially appointing a special master.

A U.S. judge rejected the DOJ's bid to force Google to sell its AdX ad exchange, ruling in favor of behavioral remedies. Google argued a sale would be disruptive. The case is part of a broader U.S. antitrust crackdown on Big Tech. Ad Manager contributed 4.1% of Google's 2020 revenue, per Wedbush.

A federal judge rejected the Justice Department's request to force Google to sell its advertising exchange, opting for behavioral changes instead. The ruling allows Google to retain the exchange, which represents a small portion of its business. Google shares rose roughly 1% on Wednesday.

Johnson & Johnson shares rose 2.7% to $278.63 after FDA approved its drug Imaavy for a rare disease, and UBS raised its price target to $320. The stock has gained 50% in the past year, nearing record highs. The company also raised its 2026 sales target above $100 billion.

Bank of America settled claims related to Jeffrey Epstein's sex-trafficking for $72.5M, with about 60 women expected to receive payments. The bank denies wrongdoing. Judge Rakoff approved the settlement, awarding lawyers 30% in fees. This is the third major bank to settle such claims, following JPMorgan Chase and Deutsche Bank.

Apnimed's sleep apnea pill AD109 has a February 28, 2027, FDA decision date. The drug showed a 44.1% reduction in breathing interruptions in trials, but the FDA questioned its clinical meaningfulness. Apnimed (APMD) relies on this single product, and its future hinges on FDA approval.